Follow the latest coverage, related explainers and connected technology stories.
Medical technology industry leaders confirmed at the AdvaMed 2026 conference that limited capital resources will push companies toward tuck-in acquisition deals and non-core asset divestitures rather than mega-mergers.
The latest agreement to fund medical device fees in the United States enjoys broad industry support, but patient groups are calling for expanded use of real-world evidence to monitor devices after they reach the market. The agreement includes higher fees for foreign companies, greater transparency regarding staffing at the medical device division, and the conversion of the TAP program into a permanent program.